Eton Pharmaceuticals Files 8-K
Ticker: ETON · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1710340
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
TL;DR
Eton Pharma filed an 8-K, check for updates.
AI Summary
Eton Pharmaceuticals, Inc. filed an 8-K on April 28, 2025, reporting other events and financial statements. The filing does not contain specific details about new events or financial figures within the provided text.
Why It Matters
This filing indicates Eton Pharmaceuticals is providing updates or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing itself is a standard disclosure and does not inherently present new risks, but the content within the full filing would need to be reviewed for specific risk factors.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Registrant
- April 28, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Deer Park, Illinois (location) — Business Address
FAQ
What specific events are being reported in this 8-K filing?
The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits', but the provided text does not detail the specific nature of these events or statements.
What is the exact date of the earliest event reported?
The date of the earliest event reported is April 28, 2025.
Where is Eton Pharmaceuticals, Inc. headquartered?
Eton Pharmaceuticals, Inc.'s principal executive offices are located at 21925 W. Field Parkway, Suite 235, Deer Park, Illinois 60010-7208.
What is Eton Pharmaceuticals' Commission File Number?
Eton Pharmaceuticals' Commission File Number is 001-38738.
Under which section of the Securities Exchange Act is this report filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).